Country antimalarial drug policies: by region
- WHO African Region
- WHO Region of the Americas
- WHO European Region
- WHO Eastern Mediterranean Region
- WHO Western Pacific Region
WHO South-East Asia Region
| Global AMDP database - WHO South-East Asia region | ||||||||
| Last Updated: December 2012 | P. falciparum | P.vivax | ||||||
| COUNTRY/ AREA | SPECIES | uncomplicated | treatment failure | severe malaria | pregnancy | treatment | ||
| un- confirmed | lab- confirmed | treatment | prevention | |||||
| Bangladesh | P.f, P.v | - | - | AL | QN+D; QN+T | - | AL - 2nd; 3rd trimester; QN | CQ+PQ(14d) |
| Bhutan | P.f, P.v | - | - | AL | QN | - | QN | CQ+PQ(14d) |
| Democratic People's Republic of Korea | P.v | - | - | - | - | - | - | CQ+PQ(14d) |
| India | P.f, P.v | - | AS+SP+PQ | AS+SP+PQ | QN+D; QN+T | - | AL - 2nd; 3rd trimester; QN | CQ+PQ(14d) |
| Indonesia | P.f, P.v | - | - | AS-AQ/DHA-PPQ+PQ | QN+D+PQ | - | AL - 2nd; 3rd trimester; QN | AS-AQ/DHA-PP+PQ(14d) |
| Myanmar | P.f, P.v | - | - | AL; AM; AS+MQ; DHA-PPQ; PQ | AS+D; AS+T | - | AL - 2nd; 3rd trimester; AS+MQ - 2nd; 3rd trimester; QN+CL | CQ+PQ(14d) |
| Nepal | P.f, P.v | - | AL+PQ | AL+PQ | - | - | QN | CQ+PQ(14d) |
| Sri Lanka | P.f, P.v | - | - | AL+PQ | - | - | AL (2nd; 3rd trimester); QN | CQ+PQ(14d) |
| Thailand | P.f, P.v | - | - | AS+MQ | QN+D | - | AS+MQ - 2nd; 3rd trimester; QN | CQ+PQ(14d) |
| Timor-Leste | P.f, P.v | - | - | AL | QN+D | - | AL (2nd; 3rd trimester); QN | CQ+PQ(14d) |
AL=Artemether-lumefantrine
D=Doxycycline
PYR=Pyronaridine
AM=Artemether
DHA=Dihydroartemisinin
QN=Quinine
AQ=Amodiaquine
MQ=Mefloquine
SP=Sulphadoxine-pyrimethamine
ART=Artemisinin
NQ=Naphroquine
T=Tetracycline
AS=Artesunate
PG=Proguanil
CL=Clindamycline
PPQ=Piperaquine
CQ=Chloroquine
PQ=Primaquine